Fagron, the leading global player in pharmaceutical compounding will host its Capital Markets Day 2025 today from 2PM CET. The event will include presentations from CEO Rafael Padilla and CFO Karin de ...

Strong revenue performance with 10.9% reported revenue growth (14.4% at CER1) and 11.3% organic growth at CER 12.3% REBITDA increase translates to 30bps REBITDA margin uplift YoY to 20.0%, reflecting ...

Fagron, the leading global player in pharmaceutical compounding, announces that the Brazilian competition authority, CADE, has granted clearance for the previously announced acquisitions of Purifarma ...

Fagron, the leading global player in pharmaceutical compounding, is pleased to announce a strategic acquisition that will significantly reinforce its presence in North America. The company has signed ...

Add Yahoo as a preferred source to see more of our stories on Google. WASHINGTON (Reuters) - Pharmaceutical supplier Fagron Holding USA LLC will pay $22.5 million to resolve allegations that its ...

Fagron, the leading global player in pharmaceutical compounding is pleased to announce the signing of two strategic acquisitions: CareFirst Specialty Pharmacy in North America and Injeplast in Brazil.

MIAMI--(BUSINESS WIRE)--Fagron North America, a leading supplier of compounded medications to hospital pharmacies and patients, will open one of the largest 503B human drug outsourcing facilities in ...

Fagron, the leading global player in pharmaceutical compounding, launches DiluCap, a new line of six excipients for compounding pharmacies allowing for easier and faster capsule formulation. Choosing ...

Rafael Padilla, CEO of Fagron: “I am incredibly pleased with the performance we delivered in 2025. Growth was broad-based across regions and segments, supported by our diversified model, disciplined ...

WICHITA, Kan., March 17, 2026 /PRNewswire/ -- Fagron Sterile Services (FSS) today announced a major milestone in strengthening the nation's supply of critical injectable medicines, with its Sterile ...

* Announces that a court case was filed on July 18th against Fagron NV, Fagron Holdings USA, LLC and certain former directors of company by one of nine former owners of Anazaohealth in U.S * Former ...